A multi-modal transcriptomic integration suggests spatial co-localization of a stromal neural-adhesion program with tertiary lymphoid structure niches in gastric cancer

Discover Oncology · Published 2026-08-01 · DOI 10.1007/s12672-026-05702-w

Free full text

Authors (6)

Yi Wang, Boyang Li, Zehao Hong, Boxiang Zhang, Yi Chen, Zhui Ke

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wang, Y., Li, B., Hong, Z., et al. (2026). A multi-modal transcriptomic integration suggests spatial co-localization of a stromal neural-adhesion program with tertiary lymphoid structure niches in gastric cancer. Discover Oncology. https://doi.org/10.1007/s12672-026-05702-w

Related articles

• Chemoradioimmunotherapy versus chemoimmunotherapy or chemoradiotherapy in extensive‐stage small‐cell lung cancer: A retrospective analysis of survival outcomes · Precision Radiation Oncology · 2025 · Cites or is cited by this article
• Radiotherapy after Neoadjuvant Immunochemotherapy in Unresectable Stage III Non‐Small Cell Lung Carcinoma: A Novel Therapeutic Approach? · Precision Radiation Oncology · 2025 · Cites or is cited by this article
• Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing · Journal of the Royal Statistical Society. Series B, Statistical methodology · 1995 · Cites or is cited by this article
• cGAS-STING pathway-related genes as candidate molecules associated with cervical intraepithelial neoplasia: an exploratory bioinformatics analysis · Discover Oncology · 2026 · Same journal
• Pan-cancer analysis and spatial validation in endometrial cancer reveal CD3D as a prognostic and immunological biomarker · Discover Oncology · 2026 · Same journal
• Systems biology approach to gene network analysis identifies therapeutic and diagnostic targets in colorectal cancer · Discover Oncology · 2026 · Same journal
• FXYD6 functions as a tumor suppressor in lung adenocarcinoma via the OIP5-AS1/miR-4735-3p/FXYD6 axis · Discover Oncology · 2026 · Same journal
• RBM15-mediated ASPM m6A modification facilitates osteosarcoma progression via IGF2BP3-dependent manner · Discover Oncology · 2026 · Same journal
• Differential expression of LYZ across pan-cancer and its prognostic value and immune microenvironment regulatory mechanisms in glioma · Discover Oncology · 2026 · Same journal
• Pan-cancer analysis identifies ODF2 as a dual prognostic and predictive biomarker for immunotherapy · Discover Oncology · 2026 · Same journal